Azulfidine EN Tab (Sulfasalazine DR)

Azulfidine EN Tab is called Salazopyrin EN Tab in Europe.

Information about Azulfidine EN Tab (Sulfasalazine DR): 

Azulfidine EN (Extended-Release) Tablets, containing Sulfasalazine, are primarily used to treat:

• Rheumatoid Arthritis: An autoimmune condition characterized by inflammation and pain in the joints.
• Ulcerative Colitis: A type of inflammatory bowel disease that causes inflammation and sores in the lining of the large intestine (colon) and rectum.
• Crohn’s Disease: Another type of inflammatory bowel disease that can affect any part of the digestive tract, but commonly impacts the small intestine and the beginning of the large intestine.

Product Highlights:

• Extended-release tablets, designed for gradual release of the medication to improve efficacy and reduce side effects.
• Sulfasalazine is a disease-modifying antirheumatic drug (DMARD) that has anti-inflammatory properties.
• Oral tablets that should be swallowed whole with plenty of fluids.

Key Ingredient:

• Sulfasalazine

Key Benefits:

• Effective in controlling symptoms of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases.
• Can help relieve pain, swelling, and joint stiffness in rheumatoid arthritis.
• Helps manage and maintain remission in ulcerative colitis and Crohn’s disease.

Directions for Use:

• Follow the dosage instructions provided by your healthcare provider. It typically starts with a low dose that may be gradually increased.
• Take the tablets whole with a full glass of water. Do not crush or chew the tablets.
• Take the medication regularly at the same time each day to maintain even levels in your bloodstream.

Safety Concerns:

• Common side effects include nausea, headache, rash, and loss of appetite. Serious side effects can include liver problems, blood disorders, or severe allergic reactions.
• Regular blood tests may be required to monitor for potential side effects, such as liver function or blood cell counts.
• May interact with other medications, including blood thinners and certain antibiotics. Inform your doctor about all other medications and supplements you are taking.

Avoid Azulfidine EN Tab (Sulfasalazine DR) If:

• You have a known allergy to sulfasalazine, sulfa drugs, or any other components of the medication.
• Should be used cautiously or avoided if you have severe liver disease, certain blood disorders, or a history of gastrointestinal obstruction.
• Use during pregnancy or breastfeeding should be discussed with your healthcare provider, as the medication may pass into breast milk or affect the fetus.